ALX Oncology Holdings, Inc.
|Number of Estimates|
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia on April 1, 2020 and is headquartered in Burlingame, CA.
Market Cap: 1.58 Billion
Primary Exchange: NASDAQ
Shares Outstanding: 36.5 Million
Float: 17.6 Million
Sector: Commercial Services
Industry: Miscellaneous Commercial Services
Longest drawdown: 4 trading days
From: 2020-07-21 To: 2020-07-27
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|